Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy

Zdeněk Kejík1,2, Jan Hajduch3,4, Nikita Abramenko3,4

  • 1BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Prague, Czech Republic. Zdenek.Kejik@lf1.cuni.cz.

Communications Chemistry
|August 13, 2024
PubMed

Insights

Cyanine dyes target cancer cell mitochondria, enhancing photodynamic and photothermal therapies (PDT and PTT). These dyes offer innovative, non-invasive treatment strategies and show promise in advanced cancer therapies.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Materials Science

Background:

  • Mitochondrial dysregulation is crucial in cancer development.
  • Mitochondria targeting is key for effective cancer therapy.
  • Photodynamic and photothermal therapies (PDT and PTT) are promising non-invasive treatments.

Purpose of the Study:

  • To review the potential and limitations of cyanine dyes for mitochondrial PDT and PTT.
  • To explore applications of cyanine dyes in combination therapies and theranostics.
  • To present novel sonodynamic therapy approaches using photoactive cyanine dyes.

Main Methods:

  • Literature review focusing on cyanine dyes in cancer therapy.
  • Analysis of dye properties, including mitochondrial selectivity and therapeutic efficacy.
  • Discussion of delivery systems and combination strategies.

Main Results:

  • Cyanine dyes exhibit strong mitochondrial selectivity, enhancing PDT and PTT efficacy.
  • These dyes show potential in theranostic applications and combination treatments.
  • Novel sonodynamic therapy applications using photoactive cyanine dyes are emerging.

Conclusions:

  • Cyanine dyes are valuable tools for mitochondrial-targeted cancer therapies.
  • Further research into optimized delivery and combination strategies is warranted.
  • Cyanine dye-based therapies represent a significant advance in non-invasive cancer treatment.